Cargando…
Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies
Psoriasis is a common chronic inflammatory skin disease, associated with substantial comorbidity. TH17 lymphocytes, differentiating under the influence of dendritic cell-derived IL-23, and mediating their effects via IL-17A, are believed to be central effector cells in psoriasis. This concept is und...
Autores principales: | Brembilla, Nicolo Costantino, Boehncke, Wolf-Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239979/ https://www.ncbi.nlm.nih.gov/pubmed/37283755 http://dx.doi.org/10.3389/fimmu.2023.1186455 |
Ejemplares similares
-
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018) -
Autoreactive T-Lymphocytes in Inflammatory Skin Diseases
por: Boehncke, Wolf-Henning, et al.
Publicado: (2019) -
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
por: Boehncke, Wolf-Henning
Publicado: (2018) -
IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020) -
Efalizumab in the treatment of psoriasis
por: Boehncke, Wolf-Henning
Publicado: (2007)